Opodo Corporation
 | |
 Opodo headquarters in Touxian | |
| Company type | Private |
|---|---|
| Industry |
|
| Founded | 1985 in Touxian |
| Founders | Abi Ancheng Ming Pak |
| Headquarters | , |
Area served | Worldwide |
Key people | Kesou Ancheng, CEO Chuanwei Yaopin, CFO |
| Products |
|
| Revenue | (2030) |
| (2030) | |
| (2030) | |
| Total assets | (2030) |
Number of employees | 26,400 (2030) |
| Subsidiaries | Parasol Pharmaceuticals |
| Website | www.opodo.dx |
Opodo Corporation commonly known as Opodo is a Daxian multinational pharmaceutical and chemicals company. Opodo's operations are focused on the Audonian markets where it is the dominant player of the sector, it operates in other continents through subsidiaries. Founded in 1985 by Abi Ancheng and renowned microbiologist Ming Pak, a leading scientist in Daxia's secret chemical weapons program. Opodo is headquartered in the city of Touxian with secondary locations and manufacturing facilities in the cities of Khov and Pianqu. In 2015 Opodo acquired the Caphirian based Parasol Pharmaceuticals. Opodo is the largest producer in the world of the drug Captagon.
History
Opodo began in 1985 as a partnership between investment banker Abi Ancheng and microbiologist Ming Pak. Amid the government push to divest itself of loss making state companies, Ancheng was able to snap up a bankrupt state company named Pigoid that specialized in asthma medications. Ancheng's plan was to use Pigoid's existing infrastructure and intellectual resources, his capital and the opening up of the pharmaceutical sector to slingshot the company to profitability. He renamed the company to Opodo and recruited the father of the Daxian chemical weapons program, Ming Pak, as a partner and to run the production side of the company. Over the next five years the company carved itself a niche in the asthma medication sector, but Ming Pak had a different notion for the company. Using components found in asthma medication such as Theophylline mixed with amphetamines, he synthetized a completely different substance; the drug Opdo would market as Captagon. Captagon would be introduced as a revolutionary medication that could be used to treat hyperactivity in children, it could be used to treat people with depression and narcolepsy. Soon enough Opdo began advertising the drug as an all-around fix for any sleep problems and perturbations, a miraculous morning pick me up, all the energy of a full breakfast in a single pill. The drug was revealed to be highly addictive but Ming Pak used his connections in government to keep regulators at bay. Whistleblowers report that with the success of Captagon, Opodo began to receive large contracts with the government to supply it with the drug for use in the penitentiary system and for coercive purposes in the colonies. Only three years after its founding, Ming Pak passed away but he left enough institutional know-how in the hands of the company that it could continue its operations.
In 2001 the company acquired a controlling stake in Canpei's Nexetina Labs, a company specializing in the fabrication of steroids. Nexetina was involved in a program run by the government of Canpei to enhance the performance of army recruits with weekly doses of anabolic steroids. With Opdo taking functional control of the program, the Daxian government quickly got wind of it and ordered Canpei to shutter it down, there being fears that the steroids program would either ruin the Canpei's regime ability to defend itself from internal threats or work too well and encourage it to act more independently. After Nexetina, Opdo continued an aggressive strategy of expansion by acquiring stakes in similar companies in Daxia's near abroad. In 2015 it bought the Caphirian based Parasol Pharmaceuticals, its first acquisition in Sarpedon; Parasol would serve as the lynchpin of all future expansion in the Vallos and Sarpedon regions.